Evidence map›Paper›PMID 30514492›Full record

ArticleTuberculosis (Edinburgh, Scotland)2018

Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Blanca I Restrepo, Léanie Kleynhans, Alejandra B Salinas, Bassent Abdelbary, Happy Tshivhula, Genesis P Aguillón-Durán, Carine Kunsevi-Kilola, Gloria Salinas, Kim Stanley, Stephanus T Malherbe and 9 more

Open access · hybridAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Characterizing poorly controlled type 2 diabetes usingMetabolomics : Official journal of the Metabolomic Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Blanca I RestrepoUniversity of Texas Health Houston, School of Public Health, Brownsville Campus, Brownsville, TX, 78520 USA; University of Texas Rio Grande Valley, South Texas Diabetes and Obesity Institute and Department of Human Genetics, Edinburg, TX, 78541 USA. Electronic address: blanca.i.restrepo@uth.tmc.edu.
Léanie KleynhansDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: leaniek@sun.ac.za.
Alejandra B SalinasUniversity of Texas Health Houston, School of Public Health, Brownsville Campus, Brownsville, TX, 78520 USA. Electronic address: alebiameysalinas@yahoo.com.
Bassent AbdelbaryUniversity of Texas Rio Grande Valley, Department of Physician Assistant, College of Health Affairs, Edinburg Campus, Edinburg, TX, 78541 USA. Electronic address: bassent.abdelbary@utrgv.edu.
Happy TshivhulaDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: tshivhula@sun.ac.za.
Genesis P Aguillón-DuránUniversity of Texas Health Houston, School of Public Health, Brownsville Campus, Brownsville, TX, 78520 USA. Electronic address: genesis.pad@hotmail.es.
Carine Kunsevi-KilolaDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: kunsevicaryn@sun.ac.za.
Gloria SalinasHidalgo County Department of Health and Human Services, Edinburg, TX, 78542 USA. Electronic address: Gloria.salinas@hchd.org.
Kim StanleyDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: kstanley@sun.ac.za.
Stephanus T MalherbeDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: malherbe@sun.ac.za.
Elizna MaasdorpDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: emaasdorp@sun.ac.za.
Moncerrato Garcia-ViverosSecretaria de Salud de Tamaulipas, Matamoros, 87370 Tamaulipas, Mexico. Electronic address: moncegarcia01@gmail.com.
Ilze LouwDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: ilzel@sun.ac.za.
Esperanza M Garcia-OropesaUniversidad Autónoma de Tamaulipas, Unidad Académica Reynosa-Aztlán, Reynosa, Tamaulipas, Mexico. Electronic address: egoropesa@docentes.uat.edu.mx.
Juan Carlos Lopez-AlvarengaUniversity of Texas Rio Grande Valley, South Texas Diabetes and Obesity Institute and Department of Human Genetics, Edinburg, TX, 78541 USA. Electronic address: juan.lopezalvarenga@utrgv.edu.
John B PrinsMater Research Institute - The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia. Electronic address: john.prins@mater.uq.edu.au.
Gerhard WalzlDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: GWALZL@sun.ac.za.
Larry S SchlesingerTexas Biomedical Research Institute, San Antonio, TX, 78227 USA. Electronic address: lschlesinger@txbiomed.org.
Katharina RonacherDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Mater Research Institute - The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia. Electronic address: katharina.ronacher@mater.uq.edu.au.
South African Medical Research Council · ZAThe University of Texas Rio Grande Valley · USBrownsville Public Library · USAutonomous University of Tamaulipas · MXMontgomery County Department of Health and Human Services · USSecretaria de Salud · MXTexas Biomedical Research Institute · USTranslational Research Institute · AU

Funding

Altered immune-endocrine axis in type 2 diabetes and tuberculosis riskR01AI116039 · NIAID · STELLENBOSCH UNIVERSITY · PI KLEYNHANS, LEANIE, RESTREPO, BLANCA I · 2015 to 2019
$1.7M
NIAID NIH HHS R01 AI116039
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is a prevalent risk factor for tuberculosis (TB), but most studies on TB-T2D have focused on TB patients, been limited to one community, and shown a variable impact of T2D on TB risk or treatment outcomes. We conducted a cross-sectional assessment of sociodemographic and metabolic factors in adult TB contacts with T2D (versus no T2D), from the Texas-Mexico border to study Hispanics, and in Cape Town to study South African Coloured ethnicities. The prevalence of T2D was 30.2% in Texas-Mexico and 17.4% in South Africa, with new diagnosis in 34.4% and 43.9%, respectively. Contacts with T2D differed between ethnicities, with higher smoking, hormonal contraceptive use and cholesterol levels in South Africa, and higher obesity in Texas-Mexico (p < 0.05). PCA analysis revealed striking differences between ethnicities in the relationships between factors defining T2D and dyslipidemias. Our findings suggest that screening for new T2D in adult TB contacts is effective to identify new T2D patients at risk for TB. Furthermore, studies aimed at predicting individual TB risk in T2D patients, should take into account the heterogeneity in dyslipidemias that are likely to modify the estimates of TB risk or adverse treatment outcomes that are generally attributed to T2D alone.

Indexed as

Black PeopleContact TracingHispanic or LatinoAdultAgedBiomarkersBlack or African AmericanBlood GlucoseDiabetes Mellitus, Type 2DyslipidemiasFemaleGlycated HemoglobinHumansLipidsMaleMass ScreeningBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanLipidsCardiovascularCholesterolDiabetesEthnicMetabolismTuberculosis

Identifiers

PMID30514492
PMCPMC6284235
OpenAlexW2888686300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.